PMID- 34401411 OWN - NLM STAT- PubMed-not-MEDLINE LR - 20210818 IS - 2352-2895 (Print) IS - 2352-2895 (Electronic) IS - 2352-2895 (Linking) VI - 15 DP - 2021 Nov TI - Vitamin A5/X controls stress-adaptation and prevents depressive-like behaviors in a mouse model of chronic stress. PG - 100375 LID - 10.1016/j.ynstr.2021.100375 [doi] LID - 100375 AB - 9-cis-13,14-dihydroretinoic acid (9CDHRA), acts as an endogenous ligand of the retinoid X receptors (RXRs), and is an active form of a suggested new vitamin, vitamin A5/X. Nutritional-relevance of this pathway as well as its detailed role in vertebrate physiology, remain largely unknown. Since recent GWAS data and experimental studies associated RXR-mediated signaling with depression, we explored here the relevance of RXR and vitamin A5/X-mediated signaling in the control of stress adaptation and depressive-like behaviors in mice. We found that compromised availability of 9CDHRA in Rbp1-/- mice was associated with increased despair in the forced swim and anhedonia in the sucrose preference test. 9CDHRA similarly to synthetic RXR agonist, BMS649, normalized despair behaviors in Rbp1-/- but not Rxrgamma-/- mice, supporting involvement of RXR signaling in anti-despair activity of these ligands. Importantly, similarly to BMS649, the 9CDHRA and its nutritional-precursor, 9-cis-13,14-dihydroretinol (vitamin A5/X alcohol), prevented development of depressive-like behaviors in mice exposed to chronic social defeat stress, revealing the beneficial role of RXRs and its endogenous ligand in stress adaptation process. These data point to the need for relevant nutritional, biochemical and pharmacological studies of this signaling pathway in human, both in physiological conditions and in pathologies of stress-related disorders. CI - (c) 2021 Published by Elsevier Inc. FAU - Krzyzosiak, Agnieszka AU - Krzyzosiak A AD - Institut de Genetique et de Biologie Moleculaire et Cellulaire (IGBMC), Inserm, U-964, CNRS UMR-7104, Universite de Strasbourg, Illkirch, France. FAU - Podlesny-Drabiniok, Anna AU - Podlesny-Drabiniok A AD - Institut de Genetique et de Biologie Moleculaire et Cellulaire (IGBMC), Inserm, U-964, CNRS UMR-7104, Universite de Strasbourg, Illkirch, France. FAU - Vaz, Belen AU - Vaz B AD - Departamento de Quimica Organica, Universidade de Vigo, Facultad de Quimica, Vigo, Spain. FAU - Alvarez, Rosana AU - Alvarez R AD - Departamento de Quimica Organica, Universidade de Vigo, Facultad de Quimica, Vigo, Spain. FAU - Ruhl, Ralph AU - Ruhl R AD - CISCAREX UG, Berlin, Germany. AD - Paprika-Bioanalytics BT, Debrecen, Hungary. FAU - de Lera, Angel R AU - de Lera AR AD - Departamento de Quimica Organica, Universidade de Vigo, Facultad de Quimica, Vigo, Spain. FAU - Krezel, Wojciech AU - Krezel W AD - Institut de Genetique et de Biologie Moleculaire et Cellulaire (IGBMC), Inserm, U-964, CNRS UMR-7104, Universite de Strasbourg, Illkirch, France. LA - eng PT - Journal Article DEP - 20210803 PL - United States TA - Neurobiol Stress JT - Neurobiology of stress JID - 101643409 PMC - PMC8355947 OTO - NOTNLM OT - Chronic stress OT - Depression OT - Mouse models OT - Retinoid receptors OT - Vitamin A COIS- A.K., A.P.-D., B.V., R.A. report no conflict of interests. W.K., A.R.d.L. and R.R. are inventors of the patent family "Precursor compounds for providing retinoids of the vitamin A5 pathway and uses thereof" PCT/HU 2017/091937, US16102137, 127356JP-18340, 127578AU-18340, 127579CN-18340, 128446CA-18340. W.K., A.R.d.L. and R.R. are shareholders of CISCAREX UG. EDAT- 2021/08/18 06:00 MHDA- 2021/08/18 06:01 PMCR- 2021/08/03 CRDT- 2021/08/17 07:32 PHST- 2021/05/12 00:00 [received] PHST- 2021/07/26 00:00 [revised] PHST- 2021/07/30 00:00 [accepted] PHST- 2021/08/17 07:32 [entrez] PHST- 2021/08/18 06:00 [pubmed] PHST- 2021/08/18 06:01 [medline] PHST- 2021/08/03 00:00 [pmc-release] AID - S2352-2895(21)00083-7 [pii] AID - 100375 [pii] AID - 10.1016/j.ynstr.2021.100375 [doi] PST - epublish SO - Neurobiol Stress. 2021 Aug 3;15:100375. doi: 10.1016/j.ynstr.2021.100375. eCollection 2021 Nov.